HUP0002925A2 - Új pentaeritritszármazékok, előállításuk, alkalmazásuk és intermedierjeik - Google Patents
Új pentaeritritszármazékok, előállításuk, alkalmazásuk és intermedierjeikInfo
- Publication number
- HUP0002925A2 HUP0002925A2 HU0002925A HUP0002925A HUP0002925A2 HU P0002925 A2 HUP0002925 A2 HU P0002925A2 HU 0002925 A HU0002925 A HU 0002925A HU P0002925 A HUP0002925 A HU P0002925A HU P0002925 A2 HUP0002925 A2 HU P0002925A2
- Authority
- HU
- Hungary
- Prior art keywords
- production
- derivatives
- pentaerythrite
- synthesis
- novel
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical class OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000013067 intermediate product Substances 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- -1 methyl- Chemical group 0.000 abstract 12
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 abstract 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 abstract 1
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
- C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Abstract
A találmány új pentaeritritszármazékokra, előállításukra,alkalmazásukra vonatkozik. A vegyületek az (I) általános képletnekfelelnek meg, amelyben Rl jelentése (II) általános képletű csoport, ésR2 jelentése C1-C20-alkilcsoport, előnyösen metil-, etil-, n-propil-,izopropil-, n-butil-, n-pentil-, n-hexil-, n-oktil-csoport, benzil-,ciklohexilmetil-, 4-klórbenzil-, 4-nitrobenzil-, 2-feniletil-, 3-fenilpropil-, 3-ciklohexilpropil-, 3-ftálimidilpropil-, 1-naftilmetil-, cinnamil-, 5-etoxikarbonilbutil-, 3-aminopropil-, -(CH2)3CH(NHCOCH3)COOH, -(CH2)3CH(NHCOCH3COOCH3 képletű csoport vagy1,6-hexán-bisz, míg m, n, o és p jelentése egész számok, amelyekreérvényes, hogy m + n + o + p = 4, m < 1 és o és/vagy p < 1. Avegyületek NO-donorok, többek között trombocita aggregációt gátló,endotélium védő és értágító hatással rendelkeznek. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19725340 | 1997-06-11 | ||
| PCT/DE1998/001635 WO1998056759A2 (de) | 1997-06-11 | 1998-06-11 | Neue pentaerythritderivate, deren herstellung und verwendung sowie intermediate zur synthese derselben |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0002925A2 true HUP0002925A2 (hu) | 2001-07-30 |
| HUP0002925A3 HUP0002925A3 (en) | 2002-11-28 |
Family
ID=7832585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0002925A HUP0002925A3 (en) | 1997-06-11 | 1998-06-11 | Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6365611B1 (hu) |
| EP (1) | EP0988282A2 (hu) |
| JP (1) | JP2002504903A (hu) |
| CN (1) | CN1266429A (hu) |
| AU (1) | AU8532198A (hu) |
| BG (1) | BG104021A (hu) |
| CA (1) | CA2293407A1 (hu) |
| DE (2) | DE19826781A1 (hu) |
| EA (1) | EA200000006A1 (hu) |
| EE (1) | EE9900568A (hu) |
| HR (1) | HRP980313A2 (hu) |
| HU (1) | HUP0002925A3 (hu) |
| IL (1) | IL133410A0 (hu) |
| NO (1) | NO996128L (hu) |
| NZ (1) | NZ501414A (hu) |
| PL (1) | PL337775A1 (hu) |
| SK (1) | SK169599A3 (hu) |
| TR (2) | TR199903054T2 (hu) |
| WO (1) | WO1998056759A2 (hu) |
| ZA (1) | ZA985064B (hu) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1306184B1 (it) * | 1999-08-05 | 2001-05-30 | Sigma Tau Ind Farmaceuti | Nitrilossi derivati della (r) e (s)-carnitina. |
| DE19950483A1 (de) * | 1999-10-19 | 2001-05-10 | Isis Pharma Gmbh | Verfahren zur Herstellung von 3-Nitryloxy-2,2-bis(nitryloxymethyl)-propanal |
| US20040009944A1 (en) * | 2002-05-10 | 2004-01-15 | Inex Pharmaceuticals Corporation | Methylated immunostimulatory oligonucleotides and methods of using the same |
| US20040013649A1 (en) * | 2002-05-10 | 2004-01-22 | Inex Pharmaceuticals Corporation | Cancer vaccines and methods of using the same |
| AU2004280143A1 (en) * | 2003-10-11 | 2005-04-21 | Tekmira Pharmaceuticals Corporation | Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3419571A (en) * | 1966-04-06 | 1968-12-31 | Warner Lambert Pharmaceutical | Method for relieving coronary insufficiency |
| DE3836021A1 (de) * | 1988-10-22 | 1990-05-03 | Boehringer Mannheim Gmbh | Arzneimittel enthaltend nitroxyalkylamine mit amidfunktion und verfahren zur herstellung dieser verbindungen |
| DE19515970A1 (de) | 1995-05-02 | 1996-11-07 | Bayer Ag | Acetylsalicylsäurenitrate |
| BR9715045A (pt) | 1996-10-10 | 2001-01-16 | Isis Pharma Gmbh | Novos derivados de pentaeritritol, processo de produção e uso e formas intermediárias para sìntese |
-
1998
- 1998-06-11 TR TR1999/03054T patent/TR199903054T2/xx unknown
- 1998-06-11 EE EEP199900568A patent/EE9900568A/xx unknown
- 1998-06-11 EP EP98936180A patent/EP0988282A2/de not_active Withdrawn
- 1998-06-11 CN CN98808056A patent/CN1266429A/zh active Pending
- 1998-06-11 DE DE19826781A patent/DE19826781A1/de not_active Withdrawn
- 1998-06-11 TR TR2000/03352T patent/TR200003352T2/xx unknown
- 1998-06-11 AU AU85321/98A patent/AU8532198A/en not_active Abandoned
- 1998-06-11 IL IL13341098A patent/IL133410A0/xx unknown
- 1998-06-11 CA CA002293407A patent/CA2293407A1/en not_active Abandoned
- 1998-06-11 DE DE19880813T patent/DE19880813D2/de not_active Expired - Lifetime
- 1998-06-11 NZ NZ501414A patent/NZ501414A/en unknown
- 1998-06-11 HR HR19725340.7A patent/HRP980313A2/hr not_active Application Discontinuation
- 1998-06-11 JP JP50133099A patent/JP2002504903A/ja active Pending
- 1998-06-11 ZA ZA985064A patent/ZA985064B/xx unknown
- 1998-06-11 US US09/445,782 patent/US6365611B1/en not_active Expired - Fee Related
- 1998-06-11 WO PCT/DE1998/001635 patent/WO1998056759A2/de not_active Application Discontinuation
- 1998-06-11 EA EA200000006A patent/EA200000006A1/ru unknown
- 1998-06-11 HU HU0002925A patent/HUP0002925A3/hu unknown
- 1998-06-11 SK SK1695-99A patent/SK169599A3/sk unknown
- 1998-06-11 PL PL98337775A patent/PL337775A1/xx unknown
-
1999
- 1999-12-10 NO NO996128A patent/NO996128L/no not_active Application Discontinuation
- 1999-12-16 BG BG104021A patent/BG104021A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1266429A (zh) | 2000-09-13 |
| TR200003352T2 (tr) | 2001-02-21 |
| DE19826781A1 (de) | 1998-12-17 |
| IL133410A0 (en) | 2001-04-30 |
| NZ501414A (en) | 2001-12-21 |
| NO996128D0 (no) | 1999-12-10 |
| BG104021A (bg) | 2000-07-31 |
| NO996128L (no) | 1999-12-10 |
| US6365611B1 (en) | 2002-04-02 |
| ZA985064B (en) | 1998-08-28 |
| WO1998056759A2 (de) | 1998-12-17 |
| JP2002504903A (ja) | 2002-02-12 |
| EP0988282A2 (de) | 2000-03-29 |
| HUP0002925A3 (en) | 2002-11-28 |
| AU8532198A (en) | 1998-12-30 |
| CA2293407A1 (en) | 1998-12-17 |
| TR199903054T2 (xx) | 2000-07-21 |
| EA200000006A1 (ru) | 2000-08-28 |
| WO1998056759A3 (de) | 1999-09-16 |
| PL337775A1 (en) | 2000-09-11 |
| EE9900568A (et) | 2000-08-15 |
| HRP980313A2 (en) | 1999-04-30 |
| DE19880813D2 (de) | 2000-05-31 |
| SK169599A3 (en) | 2000-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA00012586A (es) | Glicosulfopeptidos y metodos de sintesis y uso de los mismos. | |
| EP0254080A3 (en) | Malonic acid derivatives and methods for their synthesis | |
| HK1034912A1 (en) | Novel fatty analogues for the treatment of obesity | |
| CA2187821A1 (en) | Inherently light- and heat-stabilized polyamides | |
| BG102950A (en) | Antibodies for ed-b domain of fibronectine, their structure and application | |
| ES2115732T3 (es) | Inhibidor tumoral tetrapeptidico que incluye en su estructura fenetilamidas modificadas. | |
| ES2092958A1 (es) | Procedimiento para la sintesis de tensioactivos cationicos derivados de la condensacion de acidos grasos con aminoacidos de caracter basico esterificados y su aplicacion como agentes antimicrobianos. | |
| BR0208384A (pt) | Sìntese enantiosseletiva de compostos intermediários de azetidinona | |
| HUP0002925A2 (hu) | Új pentaeritritszármazékok, előállításuk, alkalmazásuk és intermedierjeik | |
| CA2103148A1 (en) | Determination of motifs of peptides on mhc molecules | |
| BR9808928A (pt) | Complexo molecular e liberação controlada dealfa hidroxiácidos | |
| WO2003016469A3 (en) | Chemo-enzymatic synthesis of sialylated oligosaccharides | |
| RU92004368A (ru) | Замещенные пиримидины, способ их получения, фармацевтическая композиция | |
| DE3689493D1 (de) | Verfahren zur Herstellung von reinem natürlichen Heparansulfat und Dermatansulfat und ihre pharmazeutische Verwendung. | |
| EP0743058A3 (en) | Hair care product containing a fatty acid derivative | |
| CA2320388A1 (en) | Novel dihydroxyhexanoic acid derivatives | |
| CA2155018A1 (en) | C7 taxane derivatives and pharmaceutical compositions containing them | |
| AU2223595A (en) | Aziridine derivatives, their production and use | |
| HUP9803000A2 (hu) | Ciklopeptidszármazékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
| WO1997001359A3 (fr) | Complexes metalliques de polyaminooxydes et leur utilisation en imagerie diagnostique | |
| ATE99671T1 (de) | Ceramidderivate und ihre verwendung als inhibitoren der sphingolipidsynthese. | |
| DE69027397D1 (de) | Carbohydratacryl- und -methacrylcopolymere und ihre herstellung | |
| CA2175906A1 (en) | Conversion of bisnoralcohol to bisnoraldehyde | |
| ATE92965T1 (de) | Familie von auf xanthan basierenden polysaccharidpolymeren, welche sowohl nichtacetylierten und/oder nichtpyruvylierten gummi als auch acetylierten oder nichtacetylierten polytetramer-gummi beeinhalten. | |
| ITMI950281A0 (it) | Procedimento ad alta resa per la sintesi dell'urea |